Allstate (ALL) recently reported estimated catastrophe losses of $1.72b for the second quarter of 2026, including $563m in June. Despite this, the stock has continued to outperform its sector and the broader market.
See our latest analysis for Allstate.
The strong share price momentum in Allstate, with a 1-month share price return of 13.69% and a 90-day share price return of 28.30%, comes alongside a series of earnings beats, upward earnings estimate revisions and a new 52 week high. Together these factors point to investors reassessing both the company’s growth potential and its risk profile. In a single line, Allstate’s short term share price momentum has been strong and its long term total shareholder returns, including a 3 year total shareholder return of 157.30%, have also been robust.
If you are looking beyond Allstate for what could be driving the next leg of market leadership, it is a good time to check out 18 top founder-led companies
Allstate now trades above the average analyst target, yet still appears to sell at a sizeable discount to some intrinsic value estimates. After the recent surge, is the market being too cautious on catastrophe risk, or is it already pricing the stock fairly?
Most Popular Narrative: 12.6% Overvalued
Allstate closed at $272.42 compared with a widely followed fair value narrative of $241.86, which is based on detailed earnings and cash flow assumptions using a 7.11% discount rate.
Allstate's exit from less profitable businesses (life/annuities, voluntary benefits, group health) and redeployment of capital into high-return property and casualty and protection services is expected to drive higher-quality revenue streams and enhance return on equity. Ongoing investment in technology, distribution, and customer retention programs (for example, SAVE initiative, bundling) is yielding productivity gains and strengthening competitive differentiation, likely supporting sustained growth in policies in force and upward pressure on overall earnings.
Want to understand why this narrative still points to a premium valuation even as earnings are forecast to contract sharply? The core assumptions mix modest revenue expansion, a reset in profit margins, and a higher future earnings multiple. Curious how those moving parts combine to support a fair value below today’s price and yet above analyst targets? The full narrative lays out the step by step logic behind that call.
Result: Fair Value of $241.86 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Allstate’s story can change quickly if catastrophe losses remain elevated or if tougher competition and pricing pressure start to weigh on policy growth and margins.
Find out about the key risks to this Allstate narrative.
Another View on Allstate Valuation
The narrative based on future earnings suggests Allstate is 12.6% overvalued at $272.42 versus a fair value of $241.86. Yet on a simple P/E, the stock trades at 5.8x compared with 12.4x for the US Insurance industry, 10.8x for peers, and a fair ratio of 7.8x. That gap points to a very different risk reward picture. Which lens do you trust more right now?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With sentiment on Allstate clearly split between risks and rewards, it makes sense to move quickly and assess the full picture for yourself. To see both sides in one place, start with the 4 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Allstate?
Allstate might be front of mind today, but your next strong opportunity could be sitting elsewhere. Do not leave that on the table.
- Target resilient compounding potential by scanning companies that pass a strict quality and value filter using the 49 high quality undervalued stocks.
- Boost your income focus by hunting for reliable payout candidates through the 8 dividend fortresses.
- Prioritize capital preservation by reviewing stocks with sturdier financial foundations using the 83 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com